Trial NCT01963611

View at ClinicalTrials.gov 
Org. Study IDs: EMR200575-001
Secondary IDs: 2013-002283-25

Last trial update was posted on 2016-05-11

MeSH Interventions

Glatiramer Acetate

MeSH Conditions

Multiple Sclerosis Multiple Sclerosis, Relapsing-Remitting Sclerosis

Other Conditions

Relapsing Remitting Multiple Sclerosis

Stopping Reasons

Study was terminated based on sponsor discretion.

Limitations And Caveats

Based on Sponsor decision to discontinue the clinical development program of plovamer acetate therapy for multiple sclerosis the trial was prematurely terminated

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID